HUE036797T2 - Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai - Google Patents

Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai

Info

Publication number
HUE036797T2
HUE036797T2 HUE13767175A HUE13767175A HUE036797T2 HU E036797 T2 HUE036797 T2 HU E036797T2 HU E13767175 A HUE13767175 A HU E13767175A HU E13767175 A HUE13767175 A HU E13767175A HU E036797 T2 HUE036797 T2 HU E036797T2
Authority
HU
Hungary
Prior art keywords
methods
application
oleanolic acid
heteroaryl derivatives
heteroaryl
Prior art date
Application number
HUE13767175A
Other languages
English (en)
Hungarian (hu)
Inventor
Xin Jiang
Christopher Bender
Melean Visnick
Original Assignee
Reata Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc
Publication of HUE036797T2 publication Critical patent/HUE036797T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
  • Epidemiology (AREA)
HUE13767175A 2012-09-10 2013-09-10 Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai HUE036797T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261699199P 2012-09-10 2012-09-10

Publications (1)

Publication Number Publication Date
HUE036797T2 true HUE036797T2 (hu) 2018-07-30

Family

ID=49253401

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13767175A HUE036797T2 (hu) 2012-09-10 2013-09-10 Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai

Country Status (28)

Country Link
US (1) US20140088163A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP2892911B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP6272870B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR102237364B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN104768965B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2013312102B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR112015005200B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2882417C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1119762T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK2892911T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA029069B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2644615T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20171565T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUE036797T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL237638B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2015DN01547A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LT (1) LT2892911T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ME (1) ME02911B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX366954B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ705213A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL2892911T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT2892911T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RS (1) RS56563B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG11201501800UA (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI2892911T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SM (1) SMT201700501T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2014040056A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA201501203B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI492745B (zh) 2008-01-11 2015-07-21 Reata Pharmaceuticals Inc 合成的三萜系化合物及其使用於治療疾病之方法
HUE041221T2 (hu) 2008-04-18 2019-05-28 Reata Pharmaceuticals Inc Antioxidáns gyulladás modulátorok: a C-17 atomon amino- és más módosításokkal rendelkezõ oleanolsav-származékok
TW201006474A (en) 2008-04-18 2010-02-16 Reata Pharmaceuticals Inc Natural products including an anti-flammatory pharmacore and methods of use
HUE038046T2 (hu) 2010-12-17 2018-09-28 Reata Pharmaceuticals Inc Antioxidáns gyulladáscsökkentõ pirazolil és pirimidinil triciklusos enonok
HUE035673T2 (en) 2012-04-27 2018-05-28 Reata Pharmaceuticals Inc Methyl 2,2-difluoropropionamide derivatives of Bardoxolone, their polymorphic forms and methods for their use
WO2013188818A1 (en) 2012-06-15 2013-12-19 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
TWI630212B (zh) 2012-09-10 2018-07-21 瑞塔醫藥有限責任公司 丁香油素(oleanolic acid)之c17-烷二基與烯二基衍生物及其使用方法
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
TW201936625A (zh) 2013-04-24 2019-09-16 美商艾伯維有限公司 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法
MX370586B (es) 2015-02-12 2019-12-17 Reata Pharmaceuticals Inc Imidazolil enonas triciclicas como moduladores de inflamacion antioxidantes.
CA2998681C (en) 2015-09-23 2024-02-06 Reata Pharmaceuticals, Inc. C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
US10953020B2 (en) 2016-11-08 2021-03-23 Reata Pharmaceuticals, Inc. Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof
CN106632574B (zh) * 2016-12-07 2018-05-29 广东天键生物科技有限公司 一种化合物、其制备方法及用途
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
CA3075729A1 (en) 2017-09-14 2019-03-21 Phoenix Biotechnology, Inc. Use of oleandrin to treatn viral infection
MX2020002884A (es) 2017-09-14 2020-10-05 Phoenix Biotechnology Inc Método y composición neuroprotectora mejorada para tratar afecciones neurológicas.
AU2019286531B2 (en) 2018-06-15 2024-07-18 Reata Pharmaceuticals, Inc. Pyrazole and imidazole compounds for inhibition of IL-17 and rorgamma
US12060340B2 (en) 2018-06-20 2024-08-13 Reata Pharmaceuticals, Inc Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
MX2021003643A (es) * 2018-09-28 2021-08-19 Sichuan Haisco Pharmaceutical Co Ltd Derivados de terpenoides y usos de los mismos.
CN120248001A (zh) * 2019-07-19 2025-07-04 里亚塔医药公司 C17极性的-取代的杂芳族合成三萜类化合物及其使用方法
EP4295854A3 (en) 2020-03-31 2024-04-03 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
KR102464428B1 (ko) 2020-03-31 2022-11-04 피닉스 바이오테크놀러지 인코포레이티드. 코로나바이러스 감염 치료를 위한 방법 및 조성물
JP7214696B2 (ja) * 2020-10-01 2023-01-30 一般財団法人 化学物質評価研究機構 新規in vitro皮膚感作性試験法
EP4259155A1 (en) 2020-12-11 2023-10-18 Reata Pharmaceuticals Holdings, LLC Synthetic triterpenoids for use in therapy
EP4277916A1 (en) 2021-01-18 2023-11-22 Reata Pharmaceuticals, Inc. Synthetic ursolic acid derivatives and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
CA2485565A1 (en) * 2002-05-13 2004-08-05 Trustees Of Dartmouth College Inhibitors and methods of use thereof
TWI492745B (zh) 2008-01-11 2015-07-21 Reata Pharmaceuticals Inc 合成的三萜系化合物及其使用於治療疾病之方法
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CN102164941B (zh) 2008-04-18 2015-05-27 里亚塔医药公司 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
HUE041221T2 (hu) 2008-04-18 2019-05-28 Reata Pharmaceuticals Inc Antioxidáns gyulladás modulátorok: a C-17 atomon amino- és más módosításokkal rendelkezõ oleanolsav-származékok
WO2009129548A1 (en) * 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
BR112013023174B1 (pt) * 2011-03-11 2021-09-21 Reata Pharmaceuticals, Inc Compostos derivados de triterpenoide de c4-monometila e composição farmacêutica compreendendo os referidos compostos
WO2013188818A1 (en) * 2012-06-15 2013-12-19 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof

Also Published As

Publication number Publication date
ES2644615T3 (es) 2017-11-29
ME02911B (me) 2018-10-20
ZA201501203B (en) 2021-08-25
CN104768965A (zh) 2015-07-08
CA2882417C (en) 2021-04-20
LT2892911T (lt) 2017-11-10
IN2015DN01547A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-07-03
AU2013312102B2 (en) 2018-03-08
SI2892911T1 (sl) 2017-12-29
CA2882417A1 (en) 2014-03-13
SMT201700501T1 (it) 2017-11-15
EP2892911A1 (en) 2015-07-15
BR112015005200B1 (pt) 2022-07-05
MX366954B (es) 2019-07-31
IL237638B (en) 2020-04-30
NZ705213A (en) 2018-07-27
IL237638A0 (en) 2015-04-30
DK2892911T3 (en) 2017-10-23
HK1211295A1 (en) 2016-05-20
PL2892911T3 (pl) 2018-03-30
SG11201501800UA (en) 2015-04-29
RS56563B1 (sr) 2018-02-28
JP6272870B2 (ja) 2018-01-31
PT2892911T (pt) 2017-11-02
EA201590539A1 (ru) 2015-08-31
BR112015005200A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2017-08-15
HRP20171565T1 (hr) 2017-12-15
EP2892911B1 (en) 2017-08-30
KR102237364B1 (ko) 2021-04-06
CN104768965B (zh) 2018-05-11
US20140088163A1 (en) 2014-03-27
KR20150053982A (ko) 2015-05-19
MX2015003078A (es) 2015-07-14
WO2014040056A1 (en) 2014-03-13
JP2015529227A (ja) 2015-10-05
CY1119762T1 (el) 2018-06-27
EA029069B1 (ru) 2018-02-28
AU2013312102A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
HUE036797T2 (hu) Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai
DK2892912T3 (da) C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf
HUE042516T2 (hu) Javított eljárás treprosztinilnek és származékainak elõállítására
HUE040111T2 (hu) Vegyületek és alkalmazási eljárásaik
HUE039915T2 (hu) Anthelmintikus vegyületek és készítmények és alkalmazásuk eljárása
DK2683731T3 (da) C4-monomethyl-triterpenoidderivater og fremgangsmåder til anvendelse deraf
IL242394B (en) Cenicriviroc compositions and methods of making and using the same
IL229963A0 (en) Substituted quinolines and their use as medicaments
IL238662A0 (en) Bendamustine derivatives and methods of using them
EP2798063A4 (en) PRODUCTION OF DIHYDROSTERCULIC ACID AND ITS DERIVATIVES
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
IL235968B (en) Polysaccharide compositions and methods of use
HUE046113T2 (hu) Terápiás sav ceramidáz készítmények és azok elõállítási és felhasználási eljárásai
FI20125888A7 (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
IL235909A0 (en) Heteroaryl compounds and methods of use thereof
EP2986112A4 (en) PREPARATION AND USE OF FULVINIC ACID DERIVATIVES
EP2811295A4 (en) SEPARATION AGENT AND METHOD FOR MANUFACTURING SAME
IL240447A (en) Propionic Acid-Baryl Acid Derivatives and Their Use as Pharmaceutical Preparations
PL398988A1 (pl) (Z)-6-O-ß-D-glukopiranozylo-4'-hydroksy-4-metoksy-7-prenyloauron i sposób jego wytwarzania
IL240422A0 (en) Bi-aryl derivatives of propionic acid and their use as medicinal preparations
TH1401003816A (th) องค์ประกอบ, การสังเคราะห์, และ วิธีการของการใช้อนุพันธ์ฟีนิลไซโคลอัลคิลเมทธิลเอมีน
TH1501001641A (th) อนุพันธ์กรดไฮยาลูโรนิกที่ถูกดัดแปลงและการใช้สารนั้น
TH148762B (th) อนุพันธ์ของพิร์โรลิดีน-3-อิลแอซีติก แอซิด